Literature DB >> 12667651

In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells.

Laurence Carr1, Alison Tucker, Rafael Fernandez-Botran.   

Abstract

Although dopamine receptors are present on peripheral immune system cells, relatively little is known about the functional role that dopamine may play in immune responses. The purpose of this study was to determine the effects of chronic treatment with L-dopa and dopamine on murine lymphocyte proliferation and cytokine production/release. In vivo treatment with L-dopa resulted in an increase in the proliferative response of splenic lymphocytes to ConA. Spleen cell supernatant concentrations of IL-4 and IFN gamma were not significantly altered following treatment with L-dopa for 5 days. However, the number of IFN gamma-, but not IL-4-producing cells was significantly inhibited by L-dopa. This effect was blocked by co-treatment with a dopamine antagonist. The effect on IFN gamma was replicated by infusion of dopamine. The results suggest that dopamine may have a direct role in regulating immune responses through down-regulation of IFN gamma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667651     DOI: 10.1016/s0165-5728(03)00047-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

1.  NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo.

Authors:  Anna P Mashkina; Dasha Cizkova; Ivo Vanicky; Alexander A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

2.  D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.

Authors:  Biswarup Basu; Chandrani Sarkar; Debanjan Chakroborty; Subhalakshmi Ganguly; Saurav Shome; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

Review 3.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

Review 4.  Dopamine, T cells and multiple sclerosis (MS).

Authors:  Mia Levite; Franca Marino; Marco Cosentino
Journal:  J Neural Transm (Vienna)       Date:  2017-03-10       Impact factor: 3.575

Review 5.  Close encounters of the monoamine kind: immune cells betray their nervous disposition.

Authors:  Elizabeth J Meredith; Anita Chamba; Michelle J Holder; Nicholas M Barnes; John Gordon
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

Review 6.  Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.

Authors:  Thomas J Connor
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

Review 7.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

8.  Evidence for Peripheral Immune Activation in Parkinson's Disease.

Authors:  Xueping Chen; Weihua Feng; Ruwei Ou; Jiao Liu; Jing Yang; Jiajia Fu; Bei Cao; Yongping Chen; Qianqian Wei; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2021-04-30       Impact factor: 5.750

9.  Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.

Authors:  Wei Zhao; Yan Huang; Zhan Liu; Bei-Bei Cao; Yu-Ping Peng; Yi-Hua Qiu
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 10.  Neuro-endocrine networks controlling immune system in health and disease.

Authors:  Claudio Procaccini; Valentina Pucino; Veronica De Rosa; Gianni Marone; Giuseppe Matarese
Journal:  Front Immunol       Date:  2014-04-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.